Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Japan / NCT07862088
Recruiting Observational

Management and Outcomes of Local Complications of Acute Pancreatitis and Postoperative Pancreatic Fistula

NCT07862088 · tracked via the Priya Life Science Japan tracker
Sponsor
Tokyo University
Phase
Observational
Started
2023-09-14
Last updated
2026-10-07

Condition(s) studied

Acute PancreatitisPancreatic Fluid CollectionPostoperative Pancreatic Fistula

Investigational drug(s) / intervention(s)

Routine Clinical Management of Local Complications

Routine Clinical Management of Local Complications: Participants receive routine clinical management selected by their treating clinicians. Management may include conservative treatment, endoscopic or percutaneous drainage, necrosectomy, stent placement, or surgery when clinically indicated. No diagnostic or therapeutic procedure is assigned by the study protocol.

Study summary

This multicenter prospective observational registry will evaluate the clinical characteristics and treatment outcomes of adults with local complications of acute pancreatitis or postoperative pancreatic fistula. Data generated during routine clinical care, including patient characteristics, imaging findings, treatments, adverse events, recurrence, and clinical outcomes, will be collected. Treatment is determined by the treating physicians and is not assigned by the study protocol.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Age 18 years or older. * Diagnosed with a local complication of acute pancreatitis, including acute exacerbation of chronic pancreatitis, or postoperative pancreatic fistula requiring routine clinical management. * Receiving inpatient or outpatient care at a participating institution. Exclusion Criteria: * Considered unsuitable for participation by the treating investigator. * Declines participation through the opt-out process.

Primary outcome measure(s)

  • Proportion of Participants Achieving Clinical Success Within 180 Days — Within 180 days after enrollment
    Clinical success is defined as resolution of the symptoms and clinical signs that required treatment, together with resolution or marked reduction of the target fluid collection on follow-up imaging. For infection-related cases, improvement in at least two of body temperature, white blood cell count, and C-reactive protein is required.

Trial sites (12)

FacilityCityRegionStatus
Department of Gastroenterology, Shiga University of Medical Science Ōtsu Shiga Recruiting
Department of Gastroenterology, Graduate School of Medicine, Juntendo University Bunkyō-Ku Tokyo Recruiting
The University of Tokyo Hospital Tokyo Tokyo Recruiting
Department of Gastroenterology, Tokyo Women's Medical University Tokyo Tokyo Recruiting
Department of Gastroenterology, Gifu Municipal Hospital Gifu Japan Recruiting
Department of Gastroenterology, Gifu Prefectural General Medical Center Gifu Japan Recruiting
First Department of Internal Medicine, Gifu University Hospital Gifu Japan Recruiting
Division of Hepatobiliary and Pancreatic Diseases, Department of Gastroenterology, Hyogo Medical University Hyōgo Japan Recruiting
Department of Gastroenterology and Hepatology, Saitama Medical Center, Saitama Medical University Kawagoe Japan Recruiting
Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine Kobe Japan Recruiting
Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine Ōsaka-sayama Japan Recruiting
Third Department of Internal Medicine, University of Toyama Toyama Japan Recruiting

More Tokyo University trials in Japan

Immediate Necrosectomy vs. Step-up Approach for Walled-off Necrosis Recruiting
WONDER-02 Trial: Plastic Stent vs. Lumen-apposing Metal Stent for Pancreatic Pseudocysts Starting soon
Encapsulation-oriented vs. Timing-oriented Strategies for Necrotizing Pancreatitis Starting soon
MSA-01 in Multiple System Atrophy Recruiting

Other trials for the same condition

Immediate Necrosectomy vs. Step-up Approach for Walled-off Necrosis Recruiting
WONDER-02 Trial: Plastic Stent vs. Lumen-apposing Metal Stent for Pancreatic Pseudocysts Starting soon
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07862088 on ClinicalTrials.gov ↗ ← All trials in Japan